Cytotoxicity of release products from magnetic nanocomposites in targeted drug delivery

Journal of Biomaterials Applications

Volumn 27, Issue 6, 2013, Pages 661-667

  Wamocha, H L ^a   Misak, H E ^a   Song, Z ^b,c   Chu, H Y ^d   Chen, Y Y ^d   Asmatulu, R ^a   Yang, S Y ^b,c   Ho, J C ^b,d  

^a Wichita State University   (United States)

^b WICHITA STATE UNIVERSITY   (United States)

^c Orthopaedic Research Institute Incorporated   (United States)

^d INSTITUTE OF PHYSICS   (Taiwan)

Author keywords

cytotoxicity; drug release rate; magnetic nanocomposites; Targeted drug delivery

Indexed keywords

ANTI-CANCER CHEMOTHERAPY; CYTOTOXIC EFFECTS; DRUG-RELEASE RATE; IN-VITRO; MACROPHAGE CELLS; MAGNETIC NANOCOMPOSITES; MAGNETIC NANOPARTICLES; MODEL SYSTEM; POLY(LACTIC-CO-GLYCOLIC ACID); SUSTAINED RELEASE; TARGETED DRUG DELIVERY; THERAPEUTIC AGENTS;

CELL PROLIFERATION; CHEMOTHERAPY; COPOLYMERS; DRUG DELIVERY; DRUG PRODUCTS; EMULSIFICATION; MICROSPHERES; NANOCOMPOSITES; NANOPARTICLES;

CYTOTOXICITY;

ANTINEOPLASTIC AGENT; FLUOROURACIL; LACTIC ACID; MAGNETITE NANOPARTICLE; NANOCOMPOSITE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL; ARTICLE; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DRUG DELIVERY SYSTEM; DRUG EFFECT; MACROPHAGE; MATERIALS TESTING; MOUSE; NANOTECHNOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; FLUOROURACIL; LACTIC ACID; MACROPHAGES; MAGNETITE NANOPARTICLES; MATERIALS TESTING; MICE; NANOCOMPOSITES; NANOTECHNOLOGY; POLYGLYCOLIC ACID;

EID: 84872418635     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328211421989     Document Type: Article

References (14)

1. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005 ; 26: 3995-4021
2. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003 ; 3 (5). 330-338
3. Hamdeh HH, Ho JC, Oliver SA, Willey RJ, Oliveri G, Busca G. Magnetic properties of partially-inverted zinc ferrite aerogel powders. J Appl Phys. 1997 ; 81 (4). 1851-1857
4. Hamdeh HH, Hikal WM, Taher SM, Ho JC, Thuy NP, Quy OK, et al. Mössbauer evaluation of cobalt ferrite nanoparticles synthesized by forced hydrolysis. J Appl Phys. 2005 ; 97 (6). 064310-4
5. Jeyanthi R, Rao KP. Release characteristics of bleomycin mitomycin C and 5-fluorouracil from gelatin microspheres. Int J Pharm. 1989 ; 55 (1). 31-37
6. Hou Y, Kondoh H, Ohta T, Gao S. Size-controlled synthesis of nickel nanoparticles. Appl Surf Sci. 2005 ; 241: 218-222
7. Asmatulu R, Fakhari A, Wamocha HL, Chu HY, Chen YY, Eltabey MM, et al. Drug-carrying magnetic nanocomposite particles for potential drug delivery systems. JNanotechnol. 2009 ; 2009: 238536-238536
8. Wamocha HL. Synthesis and characterization of 5-FU loaded magnetic nanocomposite spheres for advanced drug delivery. PhD Dissertation, Wichita State University, July 2010.
9. Basu B, Katti DS, Kumar A Advanced biomaterials: fundamentals, processing, and applications. Hoboken, NJ: John Wiley ; 2009 :
10. DeNardo GL, DeNardo SJ, Goldstein DS, Kroger LA, Lamborn KR, Levy NB, et al. Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma. J Clin Oncol. 1998 ; 16: 3246-3256
11. Marcos-Campos I, Asín L, Torres TE, Marquina C, Tres A, Ibarra MR, et al. Cell death induced by the application of alternating magnetic fields to nanoparticle-loaded dendritic cells. Nanotechnology. 2011 ; 22 (20). 205101-205101
12. Yu CY, Zhang XC, Zhou FZ, Zhang XZ, Cheng SX, Zhuo RX. Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems. Int J Pharm. 2008 ; 357 (1-2). 15-21
13. Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endolysosomal escape of poly (DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 2002 ; 16: 1217-1226
14. Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011 ; 63 (3). 170-183